Vertex Pharmaceuticals Incorporated is an American biotechnology company headquartered in Boston, Massachusetts, founded in 1989 in Cambridge, Massachusetts by Joshua Boger and colleagues. It became known for developing a series of drugs that treat the underlying genetic cause of cystic fibrosis, including Kalydeco and the combination drug Trikafta, and has expanded into treatments for pain and sickle cell disease and other genetic conditions.
Cross-Tradition Connections
Operates In
A major biotechnology company; classified in the atlas biotechnology-industry.
Reader Challenges (0 open reader challenges)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.
View At A Past Year
The atlas records no dated fact of its own for this entry, so there is no other year to choose.